1. Dillman RO. Antibodies as cytotoxic therapy.J Clin Oncol. 1994; 12:1497–1515.
2. Kohler G, Milstein C. Continuous cultures of fused secreting antibody of redefined specificity.Nature. 1975;256:495–497.
3. Grillo-López AJ, White CA, Varns C, et al. Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma.Semin Oncol. 1999;26(suppl 14):66–73.
4. Grillo-López AJ. The important role of monoclonal antibodies in the treatment of non-Hodgkin’s lymphomas.Oncol Spectr. 2001;2: 700–705.
5. World Health Organization.WHO Handbook for Reporting Results of Cancer Treatment. Geneva: World Health Organization, 1979:48.